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The integrin LFA-1 (CD11a/CD18) plays a critical role in the interaction of T cells with
antigen presenting cells (APCs) to promote lymphocyte differentiation and proliferation.
This integrin can be present either in a closed or in an open active conformation and its
activation upon T-cell receptor (TCR) stimulation is a critical step to allow interaction with
APCs. In this study we demonstrate that the serine/threonine kinase Ndr2 is critically
involved in the initiation of TCR-mediated LFA-1 activation (open conformation) in T cells.
Ndr2 itself becomes activated upon TCR stimulation and phosphorylates the intracellular
integrin binding partner Filamin A (FLNa) at serine 2152. This phosphorylation promotes
the dissociation of FLNa from LFA-1, allowing for a subsequent association of Talin and
Kindlin-3 which both stabilize the open conformation of LFA-1. Our data suggest that
Ndr2 activation is a crucial step to initiate TCR-mediated LFA-1 activation in T cells.
Keywords: LFA-1, TCR, Ndr2, Filamin A, Talin, Kindlin-3, inside-out signaling, T cells
INTRODUCTION
T lymphocytes require dynamic regulation of adhesive contacts for their interaction with other cell
types. An important mediator of these functions is the integrin lymphocyte function-associated
antigen-1 (LFA-1; CD11a/CD18), which is required for arrest of rolling lymphocytes on the
endothelium, extravasation into lymph nodes or inflamed tissue and interactions with antigen
presenting cells (APCs) (1).
On non-activated T cells, LFA-1 is maintained in a closed conformation with low affinity for
its ligand, the Immunoglobulin-like Cell Adhesion Molecule-1 and 2 (ICAM-1/2). Stimulation of
the T-cell receptor (TCR) by Ag/MHC-complexes induces a conformational opening of LFA-1 that
increases its affinity for ICAM-1 and facilitates avidity modulation (clustering) of LFA-1, a process
termed “inside-out signaling” (1–3). Subsequently, extracellular binding of the ICAM-1 ligands to
LFA-1 provides a co-stimulatory signal to the T cells to drive their activation, differentiation and
proliferation (“outside-in signaling”) (1, 4).
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Three intracellular binding partners of LFA-1, i.e., Filamin
A (FLNa), Kindlin-3 and Talin have been reported to regulate
inside-out-signaling of LFA-1 in T cells (1). While FLNa-
deficiency in T cells increases T-cell adhesion and LFA-1
activation (5, 6), loss of Talin or Kindlin-3 in lymphocytes
abolishes T-cell adhesion to ICAM-1 and affinity regulation of
LFA-1 (7–11). Talin, Kindlin-3 and FLNa bind to overlapping
sites within the cytoplasmic tail of the LFA-1 β2-chain (CD18)
(12, 13). Moreover, Talin competes with FLNa for binding to
the cytoplasmic tail of CD18 in vitro (14). The current model
of LFA-1 activation therefore proposes that in non-activated
T cells FLNa is bound to LFA-1 keeping the integrin in an
inactive (closed) conformation. Upon TCR-stimulation, FLNa
dissociates from CD18, Talin and Kindlin-3 are recruited to
the plasma membrane and interact with LFA-1 to promote the
activated (open) conformation. Thus, the dissociation of FLNa
from LFA-1 appears to be a critical step in this activation process.
However, the molecular mechanisms and the intracellular signals
that control the release of FLNa from CD18 are not sufficiently
understood.
The small GTPase Rap1 is key regulator of integrin activation
(15). Activated Rap1 binds to the Rap1 effector proteins regulator
for cell adhesion and polarization enriched in lymphoid tissue
(RAPL) and Rap1–GTP interacting adapter molecule (RIAM)
(16–18). Another critical component for TCR-regulated inside-
out signals is a complex consisting of the two cytosolic adapter
proteins adhesion and degranulation promoting adapter protein
(ADAP) and src kinase-associated phosphoprotein of 55 kDa
(SKAP55) (19, 20). Loss of these proteins attenuates TCR-
mediated adhesion and interaction with APCs (21–23). In this
complex SKAP55 constitutively interacts with RAPL or RIAM
(24, 25). The loss of SKAP55 or disruption of these interactions
abrogates membrane targeting of RAPL, RIAM, and Talin and
also their interaction with LFA-1 (24–28). Moreover, SKAP55
also participates in outside-signaling events regulating LFA-1-
mediated de-adhesion (29).
In addition RAPL interacts with the Ste20-like kinases Mst1,
a core component of the so-called Hippo pathway (30). Loss of
Mst1 attenuates TCR-mediated affinity regulation of LFA-1, T-
cell adhesion and interaction with APCs (10, 31–33). Mst signals
are mediated, in part, by the Nuclear Dbf2-related kinases (Ndr)
1 and Ndr2 (34, 35), which are widely expressed in mammalian
tissues including hematopoietic organs cells (36, 37). Previous
studies have demonstrated that Ndr1/2 control centrosome
duplication and alignment, cell-cycle exit, apoptosis, cell polarity
and proliferation (34, 35). Importantly, aged Ndr1-deficient mice
spontaneously develop T-cell lymphomas (38), whereas T cells
from young Ndr1/2-defcient mice are defective in thymocyte
egress and T-cell homing (36). Kondo et al. recently showed
that Ndr1 regulates TCR-mediated LFA-1 affinity by binding
to Kindlin-3 and recruitment to LFA-1 (10). In line with these
observations, we previously showed that Ndr2 controls integrin-
activation and integrin-dependent differentiation in neuronal
cells (39, 40). This led us to hypothesize that Ndr2 might play
a critical role in TCR-mediated LFA-1 activation.
Therefore, we investigated the activation of Ndr2 upon
TCR-stimulation and the critical involvement of its kinase
activity in TCR-mediated signaling processes involved in LFA-
1 activation. We identified FLNa as a substrate of Ndr2 in vitro
and demonstrated that Ndr2 phosphorylates FLNa at serine
2152 (S2152) upon TCR-triggering in vivo. We also show that
Ndr2-dependent phosphorylation of FLNa at S2152 releases the
binding of this molecule from the inactive conformation of LFA-
1, thus allowing the TCR-mediated association of Talin and
Kindlin-3 to the cytoplasmatic domain of CD18. Our data suggest
that phosphorylation of FLNa at S2152 by Ndr2 is a critical step
in TCR-mediated LFA-1 activation.
MATERIALS AND METHODS
Mice, Isolation of Lymphocytes, Cell
Culture and Transfection
C57BL/6, BALB/c, D011.10, and Ndr2−/− (40) mice were bred
and maintained under specific pathogen-free conditions at the
Otto-von-Guericke University, Magdeburg, Germany, according
to the guidelines of the State of Sachsen-Anhalt, Germany.
Animal maintenance and tissue collection were done according
to the guidelines of the State of Saxony-Anhalt, Germany and
approved by the Landesverwaltungsamt Sachsen-Anhalt (IMKI-
TWZ-02). Primary human T cells, splenic pan or CD4+ T cells as
well as B cells from mice were purified using the appropriated T-
or B-cell isolation kits and AutoMacs magnetic separation system
(Miltenyi Biotec). Approval for the isolation of human T cells
from healthy donors was obtained from the Ethics Committee of
theMedical Faculty at the Otto-von-Guericke University (79/13),
Magdeburg, Germany. Informed consent was obtained in
accordance with the Declaration of Helsinki. Jurkat T cells (JE6.1
ATCC) and B cells (Raji; ATCC) were maintained in RPMI 1640
medium (Biochrom AG) supplemented with 10% fetal bovine
serum (FBS, PAN) and stable L-glutamine at 37◦C with 5% CO2.
Jurkat T cells (2x107 cells) were transfected with plasmids by
electroporation, as previously described (41). Transfection with
the pCMS4 plasmids into Jurkat T cells consistently yielded in an
average of app. 80% GFP-expressing cell population after 48 h.
HEK 293T cells were cultured in DMEM medium containing
10% FBS and penicillin/streptomycin (100 U/ml/100µg/ml;
Biochrom AG). HEK 293T cells were transiently transfected
using the standard calcium phosphate precipitation method.
When indicated, transfected cells were treated with 1µMokadaic
acid (OA; CalbiochemMerck) for 1 h prior to harvesting.
cDNA Constructs and Generation of
Plasmids
cDNA constructs for human Ndr1, Ndr2 and its K119A
mutant cloned into the pECMV vector were described and
generously provided by Pamela A. Silver [Wyss Institute at
Harvard University, USA (42)]. Full-length Mob2 inserted into
the pEGFP-C1 vector has been previously described (42). The
dsRed-tagged cDNA constructs of wild type Filamin A (FLNa)
and its mutants (S2152A and S2152E) were kindly provided
by Miguel A. Del Pozo [Department of Vascular Biology,
Centro Nacional de Investigaciones Cardiovasculares (CNIC),
Spain; (43)]. The dsRed-C1 vector was obtained from Clontech.
Frontiers in Immunology | www.frontiersin.org 2 December 2018 | Volume 9 | Article 2852
Waldt et al. Ndr2 and LFA-1 Signaling
The pGEX 4-T-1 vector was purchased from GE Healthcare.
Repeats 19–24 of human FLNa cloned in the vector pGEX
4-T-1 was given by M. Humphries [Wellcome Trust Centre
for Cell-Matrix Research, University of Manchester, UK (44)].
The pGEX CD18 cytoplasmatic domain has been described
(45). To target FLNa with shRNA the 21-nucleotide sequence
CCCACCCACTTCACAGTAAAT was used to target by shRNA
(FLNa shRNA for/FLNa shRNA rev) and cloned into the pCMS4
vector (a gift from D. Billadeau; Department of Biochemistry
and Molecular Biology, Division of Oncology Research, Mayo
Clinic, Rochester, MN, USA). The cDNA sequences of Ndr1 and
Ndr2 were amplified to introduce the two restriction sites BglII
and XbaI needed for cloning into the pEF-BOS-FLAG vector or
pEGFP-C1 vector (Ndr2 BglII for/Ndr2 SalI/XbaI rev and Ndr1
BglII for/Ndr1 SalI/XbaI rev). To target Ndr2 by shRNA the
19-nucleotide sequence GAGGAAACACAGTTCTACA (Ndr2
shRNA for/Ndr2 shRNA rev) was used and cloned into the
pCMS4 vector. For the construction of the “suppression/re-
expression” plasmids full-length Ndr2 cDNA was amplified
and two restriction sites for Mlu1 and Not1 were introduced
to facilitate cloning into the pCMS4 vector (Ndr2 MluI
for/Ndr2 Not I rev). The QuikChange site-directed mutagenesis
kit (Agilent Technologies) was used to mutate the shRNA
target sequence to GAaGAgACgCAaTTtTAtA (lowercase letters
indicates the changed nucleotide that do not affect the amino
acid sequence) with the primer pair Ndr2 sh-res for/Ndr2 sh-
res rev. The primer pair Ndr2 K119A for/Ndr2 K119A rev was
used to generate a kinase-dead mutant of Ndr2 where lysine
119 was mutated to alanine [K119A (42)]. All amplified PCR
products were cloned into the pJET1.2 vector (Thermo Science)
and sequenced prior to sub-cloning in the designated vectors
or after mutagenesis. Please refer to Table S1 for sequences of
primers used for cloning, PCR and mutagenesis.
Antibodies
The anti-human CD3 monoclonal antibodies (mAb) (clone
OKT3; eBioscience or clone C305) and the anti-mouse CD3
mAb (non or biotinylated; clone 145-2C11; eBioscience) were
used for T-cell stimulation. The anti-human CD18 mAb (clone
MEM48; antibody-online.de), anti-human CD3 (clone OKT3) or
mAb24 (provided by N. Hogg; Cancer Research U.K. London
Research Institute, London, U.K.) were used for flow cytometric
analysis of Jurkat T cells. The following fluorescently labeled Abs
were used for purified splenic CD4+ T cells: CD4 (clone RM4-
5), CD3 (clone 145-2C11), CD18 (clone M18/2) CD11a (clone
M17/4) and CD69 (clone H1.2F3) including the appropriated
isotype controls. The anti-CD11a (clone M17/4) mAb was used
for blocking studies. These antibodies were purchased from
BioLegend. For Western blotting and immunoprecipitation the
following antibodies (Ab) were used: anti-FLAG M2 mAb, anti-
β-actin mAb, anti-Talin mAb (clone 8D4) (all from Sigma),
anti-Kindlin-3 mAb (Abcam), anti-FLNa mAb, anti-GFP mAb
(both from Santa Cruz), anti-FLNa rabbit (Abcam), anti-pFLNa
S2152 rabbit Ab, anti-pERK1/2 Thr202/Y204 rabbit Ab, anti-
pMst1/2 (Thr183)/(Thr180) rabbit Ab (all from Cell signaling),
anti-CD11a mAb (clone 38; Calbiochem Merck), anti-Mst1
mAb (from BD Bioscience) and anti-dsRed mAb (ChromoTek
GmbH). Because human Ndr1 and Ndr2 share ∼87% identity
at the amino acid level (42), the anti-Ndr2 mAb (clone 4D8;
Origene), the anti-Ndr1 goat Ab (MyBioSource), and the Ndr2
rabbit Ab (46) were tested for their specificity to detect either
Ndr1 or Ndr2 byWestern blotting (Figure S1A). In addition, the
Ndr2 rabbit Ab was used for immunoprecipitation studies and
the specificity of this antibody to recognize only Ndr2 but not
Ndr1 was addressed as depicted in Figure S1B.
Protein Purification
GST, GST-tagged Igl repeats 19–24 of human FLNa and
GST-tagged cytoplasmic domain of CD18 (GST-CD18cyt) were
expressed in BL21 (DE3) cells and purified using glutathione-
sepharose (Novagen or GE Healthcare) according to the
manufacturer’s instructions. Purity of these proteins was assessed
by SDS-PAGE followed by Commassie staining (Figure S2).
Flow Cytometry, mAb24 Binding Assay and
T Cell Activation in vitro
To analyze the cell surface expression of CD18 and CD3, Jurkat
T cells were stained with the indicated antibodies in combination
with FITC/APC-conjugated goat anti-mouse IgG (Dianova).
mAb24 binding was assessed as previously reported (47). Briefly,
cells were incubated for various time points on plate-bound anti-
IgG2a antibody or with plate-bound anti-CD3 antibody in the
presence of plate-loaded human Fc-tagged ICAM-1 (10µg/ml;
R&D system) and mAb24 antibody (10µg/ml). Bound mAb24
antibody was detected using FITC/APC-conjugated anti-mouse
IgG1 (Dianova) and analyzed by flow cytometry. Epitope
expression of mAb24 was normalized against LFA-1 expression
detected by MEM48. To analyze the cell surface expression of
purified CD4+ T cells for LFA-1 (CD18 or CD11a) or the TCR,
cells were stained with the indicated Abs. For T-cell activation in
vitro isolated splenic CD4+ T cells were stimulated with plate-
bound anti-CD3 mAbs (0.1µg/ml clone 14-2C11) in the absence
or presence of plate-bound mouse ICAM-1 Fc chimera (5µg/ml)
with or without blocking LFA-1 mAbs (15µg/ml clone M17/4)
for 12 h. Untreated (0 h) or stimulated cells (12 h) were stained
with Abs for the activation marker CD69. Ab-labeled T cells were
analyzed using a FACSCalibur flow cytometer and CellQuestPro
software (BD Biosciences).
Adhesion and Conjugation Assay
Adhesion assays were performed using a 96-well plate pre-coated
with 0.5 µg of the integrin ligand recombinant human or mouse
ICAM-1/CD54 Fc chimera/well (R&D Systems). Purified splenic
CD4+ T cells or transfected Jurkat T cells were left untreated or
stimulated with anti-CD3 mAb [145-2C11 (5µg/ml) or OKT3
(5µg/ml)] for 30min at 37◦C prior to the adhesion assay. Cells
were then allowed to adhere for 30min at 37◦C, unbound cells
were carefully washed off with Hanks buffered saline (HBSS,
Biochrom AG). Bound cells were counted and calculated as
percentage of input (2 × 105 Jurkat T cells or 1 × 106 mouse
T cells) in duplicates or triplicates (47, 48). Conjugate formation
was performed as previously described (24, 49). Briefly, untreated
or staphylococcal enterotoxin E-pulsed and DDAO-SE-labeled
Raji B cells were incubated with an equal number of Jurkat T cells
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FIGURE 1 | Expression profile, activation status and localization of Ndr2 in primary lymphocytes and lymphocyte-derived cell lines. (A) Total cell lysates of primary
human and murine lymphocytes, Jurkat T cells, Raji B cells and HEK 293T cells were analyzed by Western blotting for expression of Ndr2 and Ndr1. β-actin staining
served as loading control. Densitrometric analysis was performed to determine the Ndr2/Ndr1 ratio (n = 3; right graph). (B) Jurkat T cells were stimulated with CD3
antibodies for the indicated time points. Cells were lysed and Ndr2 was immunoprecipitated using Ndr2 rabbit antibody. Ndr2-precipitates were divided and one half
of the precipitates was used to assess Ndr2 kinase activity by an in vitro kinase assay (IVK) using the myelin basic protein (MBP) as substrate. Phosphorylation of MBP
was visualized with autoradiography. Densitrometric analysis were performed to determine the intensity of all MBP bands and values of MBP intensities from time point
0min were set to 1 (n = 2; right graph). The second half of precipitates was used to detect Ndr2 by Western blotting. Aliquots of whole-cell extracts were analyzed for
the phosphorylation status of ERK1/2 to verify successful stimulation of T cells (Input/lower panel). (C) Splenic B cells were loaded with OVA-peptide and
co-incubated with purified T cells derived from OVA-TCR transgenic DO11.10 mice for 30min. Cells were fixed, permeabilized and stained with an anti-Ndr2 Abs in
combination with anti-rabbit IgG-FITC (green). F-actin was visualized with TRITC-Phalloidin (red) (upper panel). T/B cell conjugates were stained with Cy3-labeled
anti-CD3 mAbs (red) and for Ndr2 (green; as described above; lower panel). Cells were imaged by confocal microscopy. Representative conjugates are shown. Each
study was repeated at least three times and more than 25 conjugates were examined per condition. Scale bars define 5µm. (mean ± SEM).
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for 30min at 37◦C. Nonspecific aggregates were disrupted; cells
were fixed with 1% PFA, and then analyzed by flow cytometry.
The percentage of conjugates was defined as the number of
double-positive events in the upper right quadrant. For confocal
microscopy purified splenic B cells from BALB/c mice were
loaded with 100µg/mL ovalbumin 323-339 peptide, washed and
mixed at a ratio 1:1 ratio with freshly isolated splenic CD4+ T
cells from DO11.10 mice. Cells were incubated for 30min at
37◦C on poly-L-Lysine-coated slides (Marienfeld AG) and fixed
with 3.5% paraformaldehyde (PFA) in PBS for 10min. Cells
were permeabilized with 0.1% Triton X-100 in PBS, blocked
with 5% horse serum in PBS, and incubated with Ndr2 rabbit
Abs and Cy3-labeled CD3 mAb clone 145-2C11) or Ndr2 rabbit
Abs in combination with TRITC-conjugated phalloidin (Sigma
Aldrich). Bound Ndr2 antibodies were detected with FITC-
conjugated goat anti-rabbit IgG (Dianova). Coverslips were
mounted inMowiol 488 and imagedwith a LEICATCS SP2 laser-
scanning confocal system (LeicaMicrosystems) with a Leica IRE2
stand equipped with a 63× 1.40 HCX APO CS objective (Leica),
an argon laser (488 nm), and a HeNe laser (543 nm). To avoid
spectral overlap, the samples were sequentially scanned with
a beam splitter HFT 488/543/633. Green and red fluorescence
emission were read out at 500 to 551 nm and 571 to 626 nm,
respectively. Figure constructions of images were performed in
COREL Photopaint.
Western Blotting, Immunoprecipitation and
GST Fusion Protein Pull-Down Assay
HEK 293T cells, Jurkat T cells or purified splenic CD4+ T
cells were left untreated or stimulated for various time points
with OKT3, C305 or biotinylated 14-2C11 mAbs and lysed
as previously described (24, 41, 49, 50). Equivalent amounts
of protein [determined by Bradford assay (Carl Roth)] were
used for precipitation studies (200–500 µg of total protein
from Jurkat T cells or HEK 293T cells). Cell lysates (50 µg of
total protein) or immune complexes were separated by SDS-
PAGE and transferred to nitrocellulose. Western blots were
conducted with the indicated antibodies and developed with
the appropriate horseradish peroxidase-conjugated secondary
antibodies (Dianova) and the Luminol detection system (Carl
Roth). The purified GST and GST-fusion protein of the
cytoplasmic domain of CD18 were used in GST-pull-down
experiments as previously described (51). Briefly, GST fusion
proteins bound to glutathione-sepharose were incubated with
lysates from HEK 293T cells expressing dsRed, dsRed-tagged
FLNa or its mutants for 2 h at 4◦C. Beads were washed and
analyzed by Western blotting. For quantification, the intensity of
the detected bands was calculated using the Kodak Image station
2000R (ID image software).
In vitro Kinase Assay and the
Phosphorylation Specificity for Ndr
Kinases
For in vitro kinase assays, Ndr2- or FLAG-immunoprecipitates
were divided into two equal aliquots. Both samples were pelleted
and one of each paired sample was used for Western blotting
(as described above). The remaining samples were washed
three times and suspended in kinase buffer [25mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES pH7.4),
10mM MgCl2, 1mM dithiothreitol (DTT), and 100µM [γ-
32P]ATP (∼1 µCi/µl, Perkin Elmer) or 100µM ATP (Sigma
Aldrich)] supplemented with either 5 µg myelin basic protein
(MBP; Calbiochem) or with 1 µg purified GST-FLNa 19–
24 Igl-repeats fusion protein and incubated for 30min at
30◦C. Reactions were stopped by addition of 5x sample
buffer and resolved by SDS-PAGE. Gels were either dried
and exposed to autoradiography films or were used for
Western blotting (see above). For the characterization of Ndr2
or Ndr1 substrate specificity, FLAG-tagged Ndr/GFP-Mob2
complexes were isolated as previously described (42). Kinase
reactions using the positional peptide library were performed
as previously described (52). Soluble FLAG-tagged Ndr/GFP-
Mob2 was incubated with [γ-32P]ATP (50µM, 0.025 µCi/µl)
and 198 unique peptide pools (50µM) for 2 h at 30◦C. Peptides
had the general sequence Y-A-x-x-x-x-x-S/T-x-x-x-x-A-G-K-
K(biotin), where “x” is an equimolar mixture of each of the
17 amino acids excluding Cys, Ser, and Thr. Each pool had
one of the 20 amino acids fixed at one of the nine positions
surrounding the central phosphoacceptor residue. Aliquots (2
µl) of each reaction were spotted onto streptavidin membranes
(Promega) to capture the biotinylated peptides. The membranes
were washed and exposed to a PhosphorImager as described (52).
Data were quantified using ImageQuant software (Molecular
Dynamics) and normalized so that the mean value for the 20
amino acids within a given position was 1; thus, values greater
than 1 represent positive selections whereas values less than 1
represent negative selections. Heat maps were generated from
average log2 transformed data from two independent runs using
Microsoft Excel.
Statistical Analysis
All data are presented asmean± SEM. Statistical significance was
determined between groups using a Student’s t-test. A p ≤ 0.05
was considered statistically significant.
RESULTS
Expression, Activation and Localization of
Ndr2 in Primary Lymphocytes and T/B Cell
Lines
Western blot analysis was performed to assess the expression of
Ndr2 in primary lymphocytes, T/B cell lines and HEK 293T cells.
As depicted in Figure 1A, Ndr2 is expressed in primary human
and murine lymphocytes, in the T and B cell lines (JE6.1 and
Raji, respectively) and in HEK 293T cells. In contrast to human
primary T cells, which expressed similar levels of Ndr2 and
Ndr1, lower expression levels of Ndr1 were detected in primary
murine lymphocytes, T/B cell lines, and HEK 293T cells. We next
investigated whether TCR stimulation of Jurkat T cells activates
endogenous Ndr2 (using an anti-Ndr2 antibody that specifically
precipitates Ndr2 but not Ndr1, Figure S1). Kinase activity was
assessed by an in vitro kinase assay using immunoprecipitated
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FIGURE 2 | Kinase activity of Ndr2 controls TCR-mediated adhesion, interaction of T cells with APCs and LFA-1 activation. (A) Schematic representation of the
suppression/re-expression plasmids for Ndr2 used in this study. (B) Jurkat T cells were transfected with suppression/re-expression plasmids which do not suppress
endogenous Ndr2 (shC), reduce the endogenous protein level of Ndr2 (shNdr2), re-express a FLAG-tagged shRNA-resistant wild type Ndr2 (WT Ndr2) or re-express
its kinase dead mutant (K119A Ndr2). 48 h after transfection, lysates were analyzed by Western blotting for Ndr2, Ndr1, FLAG, and β-actin (loading control). Numbers
represent the reduction and re-expression of Ndr2 and its mutant after normalization to the Ndr2 expression level of the shC-tranfected control cells, which were set to
1 (n = 4; right graph). (C) Transfected Jurkat T cells as described in (B) were analyzed for their ability to adhere to ICAM-1-coated wells in a resting state or stimulated
for 30min with CD3 antibodies. Adherent cells were counted and calculated as percentage of input (n = 4). (D) Cells were transfected as described in (B) and
analyzed for their ability to form conjugates with DDAO-SE (red)-stained Raji B cells that were pulsed without (non) or with superantigen (SA) for 30min. The
percentage of conjugates was defined as the number of double positive events in the upper right quadrant (n = 4). (E) Jurkat T cells transfected as described in (B)
were left untreated (non) or stimulated with CD3 antibodies (CD3), followed by staining with the anti-LFA-1 antibody mAb24 which recognizes the high affinity
conformation of LFA-1. mAb24 epitope expression was assessed by flow cytometry within the GFP gate and data are normalized against LFA-1 expression detected
by MEM48 (n = 4). (mean ± SEM; *p ≤ 0.05; ***p ≤ 0.001).
Ndr2 from non-activated and CD3-stimulated Jurkat T cells
and myelin basic protein (MBP) as substrate (42). An increased
phosphorylation of MBP was detected upon 5min of TCR
stimulation. Thereafter Ndr2 activity declined and reached
baseline levels at 30min after stimulation (Figure 1B, upper and
left panels). In contrast to Ndr2 activity, ERK1/2 phosphorylation
persisted for 30min, thus verifying proper T-cell stimulation
(Figure 1B, lower panel). In addition to TCR-mediated activation
of Ndr2, we studied the localization of Ndr2 at the immunological
synapse (IS). To this end, CD4+ T cells were isolated from
ovalbumin-TCR transgenic mice (DO11.10). IS formation was
induced by co-incubation with OVA peptide-loaded ex vivo
isolated B cells. The T/B cell-pairs were assessed by confocal
microscopy. As depicted in Figure 1C, Ndr2 was recruited to
the immunological synapse, where it co-localized with F-actin
(85% ± 7.48 of all analyzed T/B cell-pairs), but not with CD3.
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FIGURE 3 | Ndr2 phosphorylates FLNa at S2152 in vitro. (A) Purified WT Ndr2/Mob2 heterodimer was used to phosphorylate a positional scanning peptide library
using radiolabeled ATP. The degree of phosphorylation of each component of the library, harboring the indicated amino acid residue at the indicated position relative to
the phosphorylation site, is shown at left. Quantified data were normalized, log2 transformed, and used to generate a heat map shown at right (n = 2). (B) HEK 293T
cells were transfected with either empty pEFBOS vector (vector) or plasmids encoding FLAG-tagged wild type Ndr2 (FNdr2) and a kinase dead (K119A) mutant of
Ndr2 (FNdr2K119A). Cells were left untreated or treated with okadaic acid (OA), lysed and Ndr2 was immunoprecipitated using FLAG antibodies. A GST-FLNa
fragment (19–24 repeats) was used as substrate for an in vitro kinase assay. Reactions were analyzed by Western blotting with the indicated antibodies (n = 3). (C)
Jurkat T cells were left untreated or stimulated for the indicated time points with CD3 antibodies. Cells were lysed and analyzed by Western Blotting with the indicated
antibodies. Aliquots of whole-cell extracts were analyzed for the phosphorylation status of ERK1/2 to verify successful stimulation of T cells. Densitrometric analysis of
the FLNa phosphorylation status at Serine 2152 (pFLNa) normalized to total FLNa (tFLNa) (n = 4) (mean ± SEM; **p ≤ 0.01).
This indicates that Ndr2 is localized at the peripheral part of
the IS. In summary, the data shown in Figure 1 indicate (i)
that Ndr2 is expressed in lymphocytes, (ii) that it is rapidly and
transiently activated upon TCR-stimulation and (iii) recruited to
the cytoskeleton-enriched region of the IS.
Kinase Activity of Ndr2 Is Required For
TCR-Mediated Adhesion, Interaction With
APCs and LFA-1 Activation
To address the functional importance of Ndr2 for TCR-mediated
LFA-1 signaling, we generated suppression/re-expression
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FIGURE 4 | Ndr2 phosphorylates FLNa at S2152 in Jurkat T cells in vivo. (A) Jurkat T cells were transfected with suppression/re-expression constructs which
suppress endogenous Ndr2 (shNdr2) and re-express a FLAG-tagged shRNA-resistant wild type (WT Ndr2) or a kinase-dead mutant of Ndr2 (K119A Ndr2). Numbers
represent the reduction and re-expression of Ndr2 and its mutant after normalization to the Ndr2 expression level of the shC-tranfected control cells. (B) At 48 h
post-transfection, cells left untreated or stimulated for the indicated time points with CD3 antibodies. Cells were lysed and analyzed by Western Blotting with the
indicated antibodies. Densitrometric quantification of FLNa phosphorylation at Serine 2152 (pFLNa) normalized to total FLNa (tFLNa) (n = 3). (mean ± SEM;
**p ≤ 0.05).
plasmids that knock down endogenous Ndr2 and simultaneously
re-express FLAG-tagged shRNA-resistant wild type (WT Ndr2)
or FLAG-tagged kinase dead mutant of Ndr2, carring a mutation
of lysine 119 to alanine [K119A Ndr2 (42)] (Figure 2A).
As shown in Figure 2B, the suppression construct (shNdr2)
strongly reduced endogenous Ndr2 levels when compared to
vector control levels (shC). In addition, the suppression/re-
expression plasmids allowed proper re-expression of either
WT or K119A mutant of Ndr2, respectively. Importantly,
suppression of Ndr2 and re-expression of Ndr2-forms did not
alter the endogenous expression levels of Ndr1 (Figure 2B).
As depicted in Figures 2C,D, downregulation of Ndr2 in
Jurkat T cells diminished their ability to adhere to ICAM-1
(Figure 2C) and to interact with superantigen-pulsed B cells
(Figure 2D). Re-expression of the shRNA-resistant WT Ndr2
rescued the ability of the cells to adhere to ICAM-1 and to
interact with APCs (Figures 2C,D). In contrast to WT Ndr2
re-expressing cells, re-expression of the K119A mutant of
Ndr2 did not rescue TCR-mediated adhesion to ICAM-1 or
interaction with superantigen-pulsed B cells (Figures 2C,D). Of
note, the attenuated T-cell adhesion and interaction with APCs
were not due to altered expression levels of the TCR or LFA-1
(Figure S3A).
To investigate whether Ndr2 affects the TCR-induced affinity
state of LFA-1, we took advantage of the conformation-specific
antibody mAb24. This antibody specifically binds only the high
affinity conformation of LFA-1, which is required for ligand
binding (1). Indeed, suppression of Ndr2 in T cells interfered
with the TCR-mediated induction of the mAb24 epitope within
LFA-1 compared to shC-transfected cells (Figure 2E). Re-
expression of WT Ndr2 rescued the ability of mAb24-binding
to LFA-1 in response to TCR stimulation whereas this was
not the case in cells re-expressing the K119A mutant of Ndr2
(Figure 2E). In summary, these findings suggest that TCR-
mediated adhesion, interaction of T cells with APCs and affinity
modulation of LFA-1 require enzymatically active Ndr2 in Jurkat
T cells.
Ndr2 Phosphorylates FLNa at Serine 2152
Having shown that enzymatically active Ndr2 is required for
TCR-induced affinity modulation of LFA-1 (Figure 2E) we next
asked which integrin-activity modulator might be controlled
by Ndr2. To this end, we first determined the amino acid
motifs phosphorylated by Ndr2, using FLAG-tagged Ndr2/GFP-
Mob2 complex from HEK 293T cells and a positional peptide
library as previously described (42, 52). Using this approach we
identified an R-X-P-S/T motif as an optimal sequence for Ndr2
kinase (Figure 3A). A qualitatively similar sequence preference
was observed for the Ndr1-Mob2 complex (Figure S4B).
Reactions performed with catalytically-inactive FLAG-tagged
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FIGURE 5 | Ndr2-deficiency in murine CD4+ T cells attenuates TCR-induced FLNa phosphorylation at S2152, T-cell adhesion and LFA-1-dependent upregulation of
CD69 in vitro. (A) Purified splenic wild type (WT) and Ndr2−/− CD4+ T cells were left untreated or stimulated with anti-CD3 antibodies for the indicated time points.
Lysates were prepared and analyzed by Western blotting using the indicated antibodies. Densitrometric quantification of FLNa phosphorylation at Serine 2152 (pFLNa)
normalized to total FLNa (tFLNa) (n = 3). (B) Purified splenic WT and Ndr2−/− CD4+ T cells were left untreated (non) or stimulated with anti-CD3 antibodies (CD3)
and subsequently analyzed for their ability to bind plate-bound Fc-ICAM-1. Adherent cells were counted and calculated as percentage of input (n = 3). (C) Purified
splenic CD4+ T cells from WT and Ndr2 mice were cultured with plate-bound anti-CD3 antibodies (CD3) in the absence or presence of Fc-ICAM-1 (ICAM-1) with or
without blocking LFA-1 antibodies (LFA-1) for 12 h. The upregulation of the activation marker CD69 of unstimulated (0 h) or activated T cells (12 h) were assessed by
flow cytometry to determine the mean fluorescence intensity (MFI) (n = 3). (mean ± SEM; *p ≤ 0.05, **p ≤ 0.01).
Ndr2 mutant (K119A)/GFP-Mob2 exhibited negligible kinase
activity (Figure S4A), demonstrating that the radiolabeled
peptides were not phosphorylated by a contaminating kinase
that accidently was co-purified with Ndr2. The elevated signals
for serine residues at multiple positions are likely due to the
presence of two potential phosphoacceptors within the peptide.
Threonine signals were not similarly elevated, suggesting that
Ndr2 prefers to phosphorylate serine residues over threonine,
at least in vitro. This preference was also reflected in the
relative phosphorylation by Ndr2 of peptides having either serine
or threonine as the sole phosphoacceptor residue [personal
communication by J. L. Johnson and L. Cantley (Meyer
Cancer Center, Weill Cornell Medicine College, New York,
USA)].
Using integrin-activity modulation as a criterion, an online
protein database search revealed that FLNa, a previously
described negative regulator of LFA-1 activation (5, 6), contains
a suitable “RXPS” motif at the serine 2152 (S2152). Since
phosphorylation of this motif has been shown to reduce focal
adhesion formation (53) we further investigated the FLNa S2152
phosphorylation site as a putative target of Ndr2 kinase. In
order to address whether Ndr2 directly phosphorylates FLNa
at S2152, we performed an in vitro kinase assay using FLAG-
tagged wild type Ndr2 immunoprecipitated from HEK 293T
cells (42). Prior to immunoprecipitation of Ndr2, transfected
cells were left untreated or stimulated with okadeic acid
(OA) for 1 h, a phosphatase inhibitor and known activator
of Ndr2 (42). Using the GST-fusion protein of a C-terminal
fragment of FLNa (immunoglobulin-like (Igl) repeats 19–24 of
human FLNa) containing the S2152 phosphorylation site as
substrate, we detected S2152-specific phosphorylation after OA-
stimulation, but not in untreated FLAG-tagged wild type Ndr2
expressing cells (Figure 3B). In contrast, a K119 mutant of Ndr2
precipitated from OA-stimulated cells did not phosphorylate
FLNa at S2152 (Figure 3B) excluding an unspecific FLNa S2152
phosphorylation effect by a co-precipitated kinases. These data
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FIGURE 6 | Mutation of S2152A within FLNa abolishes TCR-mediated T-cell adhesion, interaction with APCs and LFA-1 activation. (A) Jurkat T cells were transiently
transfected with dsRed C1 vector (dsRed) or plasmids encoding wild type (WT) dsRed-tagged FLNa (FLNa WT) or dsRed-tagged S2152A or dsRed-tagged S2152E
FLNa mutants (FLNa S215A and FLNa S2152E). After 24 h the expression of WT and its mutants were analyzed by anti-dsRed and FLNa immunoblotting. Detection
of β-actin served as loading control. (B) Jurkat T cells transfected as described in (A) were left untreated (non) or stimulated for 30min with CD3 antibodies. Cells were
analyzed for adhesion to ICAM-1-coated 96 well plates. Bound cells were counted and calculated as percentage of input (n = 4) (mean ± SEM; *p ≤ 0.05, ***p ≤
0.001). (C) Cells were transfected as described in (A) and analyzed for their ability to form conjugates with DDAO-SE (red)-stained Raji B cells that were pulsed
without (non) or with superantigen (SA) for 30min at 37◦C. The percentage of conjugates was defined as the number of double-positive events in the upper right
quadrant (n = 4) (mean ± SEM; ***p ≤ 0.001). (D) Jurkat T cells transfected as described in (A) were left untreated (non) or stimulated with anti-CD3 antibodies (CD3),
followed by staining with the anti-LFA-1 antibody mAb24 to detect the high affinity conformation of LFA-1. mAb24 epitope expression was assessed by flow
cytometry and data are normalized against LFA-1 expression detected by MEM48 (n = 4) (mean ± SEM; ***p ≤ 0.001). (E) HEK 293T cells were transfected with
either dsRed, dsRed-tagged FLNa wild type (FLAa WT) or its mutants (FLNa S2152A and FLNa S2152E). 24 h after transfection, whole cell extracts were prepared
and analyzed for the expression of dsRed and dsRed-tagged FLNa forms by Western blotting using the indicated antibodies (left panel). Lysates were incubated with
GST-fusion proteins bound to glutathione-sepharose beads. Precipitates were analyzed by Western blotting using the indicated antibodies (right panel). One
representative experiment of 3 is shown. (mean ± SEM; *p ≤ 0.05, ***p ≤ 0.001).
suggest that Ndr2 is able to phosphorylate FLNa at S2152 in
vitro.
Next, we analyzed the phosphorylation status of FLNa at
S2152 upon TCR-triggering in Jurkat T cells. As depicted in
Figure 3C, TCR-stimulation induced the phosphorylation of
FLNa at S2152, which peaked at 5min and remained at this
level for 30min. Note that the expression levels of FLNa were
not changed upon TCR-stimulation (Figure 3C). Having shown
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FIGURE 7 | TCR-stimulation of Jurkat T cells releases LFA-1 from FLNa. (A) Jurkat T cells were left untreated or stimulated for the indicated time points with CD3
antibodies. Lysates were prepared and used for immunoprecipitation of FLNa. Precipitates were analyzed by Western blotting for the phosphorylation status of FLNa
at S2152 and LFA-1 association. Aliquots of whole-cell extracts were analyzed for the phosphorylation status of ERK1/2 to verify successful stimulation of T cells
(lower panel; Input). (B) Densitrometric analysis of the FLNa phosphorylation status at Serine 2152 (pFLNa) normalized to precipitated total FLNa (tFLNa) or of LFA-1
to precipitated total FLNa (tFLNa) (n = 4). (mean ± SEM; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001).
that TCR-stimulation induces phosphorylation of FLNa at S2152,
we examined whether loss of Ndr2 or its kinase activity would
alter S2152 phosphorylation of FLNa. As shown in Figures 4A,B,
silencing of Ndr2 expression in Jurkat T cells strongly reduced
S2152 phosphorylation of FLNa upon TCR stimulation. Re-
expression of WT Ndr2 rescued the phosphorylation status
of FLNa at S2152 to a similar extent as found for shC-
transfected cells. In contrast to wild type Ndr2 expressing cells,
re-expression of the K119A mutant of Ndr2 attenuated TCR-
mediated S2152 phosphorylation of FLNa (Figures 4A,B). Taken
together the data depicted in Figures 3 and 4 indicate that Ndr2
phosphorylates FLNa at S2152 both in vitro and in vivo.
To verify whether Ndr2-deficiency attenuates TCR-mediated
phosphorylation of FLNa in murine T cells, we isolated CD4+
T cells from wild type and Ndr2−/− knockout mice (40). Note
that in line with previously published data by Tang et al. (36),
loss of Ndr2 in mice did not affect thymic development or
CD4+ and CD8+ T-cell distribution in the spleen and lymph
node (data not shown). As shown in Figure 5A, TCR-stimulation
induced the phosphorylation of FLNa at S2152 in wild type
CD4+ T cells with a similar phosphorylation kinetic in shC-
transfected Jurkat T cells which peaked at 5min and remained
at this level for 30min. In contrast to wild type CD4+ T cells,
TCR-induced S2152 phosphorylation of FLNa was abrogated in
Ndr2−/− CD4+ T cells. Similar to downregulation of Ndr2 in
Jurkat T cells, Ndr2−/− CD4+ T cells showed diminished ability
to adhere to ICAM-1 (Figure 5B). Importantly, the attenuated
TCR-mediated phosphorylation of FLNa and T-cell adhesion of
Ndr2−/− CD4+ T cells were not due to altered expression levels
of FLNa, the TCR (CD3) or LFA-1 (Figure S3C).
ICAM-1-binding to the high affinity conformation of LFA-
1 in T cells induces co-stimulatory signaling pathway(s) that
enhances the TCR-mediated CD69 upregulation (54, 55). Hence
we analyzed the upregulation of CD69 upon TCR stimulation
in the absence or presence of plate-bound ICAM-1. As depicted
in Figure 5C the upregulation of this activation marker was
significant increased in the presence of TCR/ICAM-1 in WT
CD4+ T cells. The addition of a LFA-1 blocking Ab to these cells
reduced the CD69 expression to similar levels as detected for
TCR-stimulation alone, showing that these processes were indeed
LFA-1 dependent. In contrast to WT CD4+ T cells, loss of Ndr2
did not lead to an enhanced TCR/ICAM-1-induced expression
of this marker compared to WT T cells. The expression levels
of CD69 was not different in Ndr2-deficient CD4+ T cells
upon TCR- stimulation in the absence or presence ICAM-1
and moreover comparable with TCR-stimulated WT T cells
(Figure 5C). Together, the data presented in Figure 5 reveal a
crucial role of Ndr2 for TCR-induced inside-out and outside-in
signaling.
Overexpression of FLNa and Its S2152A
Mutant Attenuates TCR-Mediated
LFA-Activation
Previously it had been shown that loss of FLNa induces
spontaneous LFA-1 activation in the non-stimulated pro-B-cell
line BAF (6). In line with this study, suppression of FLNa
expression in Jurkat T cells (Figure S5A) induced constitutive
and enhanced TCR-stimulated adhesion to ICAM-1, interaction
with APCs and LFA-1 affinity modulation (Figures S5B–D),
while not affecting the expression of the TCR or LFA-
1 (Figure S5E). We speculated that overexpression of wild
type FLNa would impede TCR-mediated adhesion and T-cell
interaction with APCs. Indeed, Jurkat T cells overexpressing
WT FLNa showed approx. 50% decreased adhesion to ICAM-1
compared to control cells upon TCR-stimulation (Figures 6A,B).
Similarly, WT FLNa expressing Jurkat T cells showed an
attenuated capability to interact with superantigen-loaded B
cells (Figure 6C). In line with these observations, we found
that cells overexpressing the dsRed-tagged FLNa S2152A mutant
(mimics loss of phosphorylation S2152) attenuated TCR-
mediated adhesion of Jurkat T cells to ICAM-1 (Figure 6B)
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FIGURE 8 | Activated Ndr2 releases FLNa binding from LFA-1. (A) Jurkat T
cells were transfected with constructs that suppress endogenous Ndr2
(shNdr2) and re-express a FLAG-tagged shRNA-resistant wild type (WT Ndr2)
or a kinase-dead mutant of Ndr2 (K119A Ndr2). 48 h after transfection,
whole-cell extracts were prepared and analyzed by Western blotting using the
indicated antibodies. Numbers represent the reduction and re-expression of
Ndr2 and its mutant after normalization to the Ndr2 expression level of
shC-tranfected control cells. (B,C) Cells left untreated or stimulated for the
indicated time points with CD3 antibodies. Lysates were used for
immunoprecipitation of LFA-1 using anti-CD11a antibodies. Precipitates were
divided and analyzed by Western blotting for FLNa, Talin and Kindlin-3
association. Densitrometric analyses of FLNa, Talin, or Kindlin-3 associated to
LFA-1 are depicted in Figure S8.
and the interaction with APCs (Figure 6C). In addition, both
overexpressing WT FLNa and its S2152A mutant in Jurkat
T cells completely blocked the induction of the high affinity
conformation of LFA-1 upon TCR stimulation (Figure 6D). Flow
cytometric analysis revealed comparable levels of CD18 and
the TCR on the surface of these FLNa WT or FLNa S2152A
expressing Jurkat T cells (Figure S3B).
In contrast toWT FLNa and the S2152Amutant, Jurkat T cells
expressing a S2152E mutant of FLNa (mimics phosphorylation
of S2152) showed similar levels of TCR-mediated adhesion,
interaction with APCs and LFA-1 activation compared to dsRed
expressing cells. These data suggest that bothWT and the S2152A
mutant of FLNa act in a dominant negative fashion for TCR-
mediated LFA-1 activation.
Given the above data, we speculated that in contrast to FLNa
S2152E, WT FLNa and its S2152A mutant still interact with
the cytoplasmic region of CD18. To answer this question, we
transfected HEK293T cells with dsRed only, dsRed-tagged FLNa
WT and its two S2152A vs. S2152E mutants. Cell lysates were
used for precipitation using either purified GST or GST-CD18cyt,
respectively. Using this approach we detected an association of
the GST-CD18cyt fusion protein only with WT [in line with
previously published data (6)] and S2152A FLNa but not with
the S2152E FLNa mutant (Figure 6E). These data indicate that
the phosphorylation of S2152 of FLNa attenuates the interaction
with the cytoplasmatic region of the β2-chain of LFA-1.
Activated Ndr2 Promotes FLNa Release
From LFA-1
In non-activated T cells, FLNa is bound to LFA-1 and stabilizes
its closed conformation (6). We hypothesized that stimulation
of the TCR releases LFA-1 from FLNa and further that, this
event correlates with an increased phosphorylation status of
FLNa at S2152. To test this idea, we immunoprecipitated FLNa
from non-stimulated and TCR-stimulated Jurkat T cells. In
resting Jurkat T cells, we detected an association of FLNa with
LFA-1 (Figures 7A,B). Triggering of the TCR induced rapid
LFA-1 dissociation from FLNa which correlated with increased
phosphorylation of S2152 (Figures 7A,B).
Next, we assessed whether the Ndr2-mediated
phosphorylation of FLNa at S2152 releases FLNa from LFA-1
and thus allowing binding of the two integrin activating proteins
Talin and Kindlin-3 to LFA-1 and promote LFA-1 activation. To
test this hypothesis, we immunoprecipitated LFA-1 from non-
activated and TCR-stimulated Jurkat T cells and assessed binding
of Talin and Kindlin-3, respectively. In resting shC-transfected
Jurkat T cells, we detected an association of FLNa with LFA-1,
whereas Talin or Kindlin-3 interaction with LFA-1 was detectated
only at low levels. Upon TCR-stimulation, FLNa association with
LFA-1 declined within 30min while Talin/Kindlin3 association to
LFA-1 increased (Figures 8A,B). Importantly, downregulation
of Ndr2 abrogated the TCR-inducible association of these
two LFA-1 interacting proteins (Figure 8B). In contrast, in
cells re-expressing the catalytically inactive mutant of Ndr2
(K119A Ndr2), TCR-stimulation did not induce the release of
FLNa from LFA-1 and consequently the recruitment of Talin
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and Kindlin-3 to LFA-1 was blocked (Figure 8C). WT Ndr2
expressing cells by contrast showed similar FLNa disassociation
dynamics as shC-transfected cells (Figure 8C). In summary our
findings suggest that TCR-mediated activation of Ndr2 leads
to phosphorylation of FLNa at S2152. This releases FLNa from
LFA-1 and subsequently allows the association of Talin and
Kindlin-3 thus inducing LFA-1 activation.
DISCUSSION
In this study we report that Ndr2 kinase activity is required
for TCR-mediated LFA-1 affinity regulation to facilitate T-cell
adhesion and interaction with APCs. Our data reveal that
Ndr2 supports LFA-1 activation during T-cell activation by
phosphorylating FLNa at S2152 and by triggering its release from
the cytoplasmic chain of CD18.
Ndr kinases are highly conserved; however, cell-type specific
expression levels as well as spatial and conformational constraints
on activation and enzyme-substrate interactions may result in
isoform specificity of the two mammalian Ndr isoforms Ndr1
and Ndr2. Here, we focused on the role of Ndr2 rather than on
the previously studied Ndr1 (10), as we found a predominant
expression of this isoform in Jurkat T cells as well as in murine T
cells and because we observed its prominent recruitment to the
IS upon TCR stimulation. Importantly, knockdown/knockout
and/or re-expression of Ndr2 did not affect Ndr1 expression in
Jurkat T cells, in line with our previous observations in themouse
brain (40).
Our data indicate that Ndr2 is activated within 5min
after TCR stimulation. However, how TCR-mediated Ndr1/2
activation is achieved in T cells remains unsolved. Activation
of Ndr kinases generally requires the phosphorylation of the C-
terminal hydrophobic motif (pThr442/444) through Mst1 and
Mst3 kinases and N-terminal binding of the Mob protein as a
co-activator (36, 42, 56). While the role of Mob proteins in T
cells is still unclear, it has recently been shown that Ndr1 and/or
Ndr2 are phosphorylated and activated in an Mst1/2-dependent
manner upon chemokine and TCR-stimulation of murine T cells
(10, 36). As depicted in Figure S6, we confirmed that loss of
Ndr2 does not affect the phosphorylation status of either Mst1
nor Mst2 upon TCR-stimulation, suggesting that in Jurkat T cells
Ndr2 is located downstream of Mst kinases and can be activated
by these kinases upon TCR-stimulation.
In an unbiased screen we identified an RXPT/S motif as
putative phosphorylation site for Ndr2. We demonstrated that
the corresponding motif around serine 2152 of FLNa is a target
site for Ndr2 kinase in vitro and in vivo. Serine 2152 within FLNa
represents the main phosphorylation site as shown by several
studies. Treatment of cells with various stimuli e.g., insulin
(53), insulin-like growth factor-I (57), epidermal growth factor
(58), arsenic (59), cAMP or agonists that increase intracellular
cAMP levels (60–64) leads to S2152 phosphorylation of FLNa
in epithelial, platelets, smooth muscle cells, cancer cells and
fibroblasts, respectively. To our knowledge, this is the first report
showing that TCR-stimulation also triggers the phosphorylation
of FLNa at S2152.
Similar to TCR stimulation, triggering of the monocyte
chemokine receptor 2 (CCR2) also leads to phosphorylation
of FLNa at S2152 (65). Further, stimulation of the chemokine
receptor CCR7 induces activation of Ndr kinases in thymocytes
(36). CD4+ or CD8+ single positive thymocytes from Ndr1/2-
double deficient mice are defective in response to CCL19 (ligand
of CCR7)-induced transwell migration (36). Therefore, it is
possible that Ndr kinases are also activated upon chemokine
triggering to phosphorylate S2152 of FLNa, regulating adhesive
and/or migratory response(s) of these T cells.
As depicted in Figure 6, our data reveal that overexpression
of a S2152A mutant of FLNa attenuates TCR-mediated LFA-1
affinity modulation (to a similar extend then wild type FLNa) and
subsequently leads to impaired T-cell adhesion and interaction
with APCs. FLNa contains 24 immunoglobulin-like repeats (Igl-
repeat), with a binding site for the cytoplasmic domain of
the LFA-1 β2-chain in the Igl-repeat 21 (5) and the S2152
phosphorylation site in Igl-repeat 23. We observed that wild
type FLNa [in line with previously published data (6)] and FLNa
S2152A, but not the FLNa mutant that mimics phosphorylation
(S2152E) interact with the GST-CD18cyt fusion protein. These
data suggest that Ndr2-mediated phosphorylation of S2152
residue on Ig1-repeat 23 might lead to conformational changes
within FLNa that reduce its binding affinity to the cytoplasmatic
domain of the β2-chain of LFA-1.
The current models for LFA-1 affinity modulation suggest
that inside-out signals mediate direct interaction of Talin and
Kindlin-3 to the cytoplasmic domain of CD18 separating the
α/β cytoplasmic tails. The binding of these molecules induces
changes within the integrin structure resulting in a shift from
the low affinity to intermediate and high affinity conformation
(1, 2). Talin was shown to induce the intermediate conformation
(9) whereas Kindlin-3 was required for the high affinity
conformation and stabilization of LFA-1/ICAM-1 binding (66).
SKAP55 was described to interact with RIAM that binds to
Talin (18, 24) or with RAPL linked to Mst1 (25, 31). RAPL was
shown to bind to the cytoplasmic domain of CD11a (16). It
might be that activated Ndr2 (through Mst1 and Mob1) alone or
in the context with SKAP55/RAPL/Mst1/Mob1-complex bound
to the cytoplasmic domain of CD11a is a prerequisite for
FLNa phosphorylation at S2152 and its release. Subsequently,
SKAP55 bound via RIAM to Talin interacting with CD18 induces
the intermediate conformation, which in turn allows Kindlin-
3 (either sequentially or simultaneously) binding to CD18
stabilizing the high affinity conformation of LFA-1.
The high affinity conformation of LFA-1 mediates T-cell
adhesion (and interaction with APCs). Similar to affinity
regulation avidity modulation (clustering) has been thought
to increase contact numbers and stabilize adhesion. However,
recently Raab et al. showed that clustering and cross-linking
of LFA-1 during maturation of the IS reduces or terminates
adhesion (or interaction with APCs) (29). They proposed a
model that cross-linked LFA-1 activates Focal Adhesion Kinase
1 (FAK1), which phosphorylates the linker for the activation of
T cells (LAT) at Y171. This pY171 provides a docking site for
a complex consisting of growth-factor-receptor bound protein
2 (Grb2) and SKAP55 (29). As depicted in Figures 2 and 5 our
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data reveal that Ndr2 provides a positive regulatory signal for
affinity modulation of LFA-1 leading to adhesion and activation
of T cells. Since Mst1-deficient T cells exhibit a defect in LFA-1
clustering (32) it is likely that activatedNdr2 throughMst1/Mob1
modulates LFA-1 clustering and FAK1 activity to terminate
adhesion.
Previous studies using Talin-deficient CD4+ T cells or CD4+
T cells expressing a LFA-1 mutant deficient in Kindlin-3 binding
showed an attenuated antigen-specific CD4+ T-cell activation in
vivo (9, 67). Therefore it is likely that loss of Ndr2 in CD4+ T cells
would also interfere with interaction of APCs to promote T-cell
activation and proliferation in vivo. Clearly further experiments
are required to address these issues.
Based on these observations we suggest the following
molecular interaction model (Figure S7): TCR-mediated
activation of Ndr2 probably by Mst1/2 kinases (step 1) leads to
phosphorylation of FLNa at S2152 (step 2). This phosphorylation
event releases FLNa from LFA-1 (step 3), thereby allowing the
association of Talin and Kindlin-3 with LFA-1 (step 4). The
inducible interaction with Talin and Kindlin-3 will mediate the
induction of the high affinity status of LFA-1 (step 5). Strikingly,
the activation dynamics of Ndr2 are comparable to the increase of
FLNa phosphorylation at S2152 and Talin/Kindlin-3 association
with LFA-1, all of which can be detected within 5min after TCR
stimulation. However, Ndr2 activity appears to decay faster than
the FLNa phosphorylation levels of S2152 and the formation of
the LFA-1/Talin/Kindlin complex indicating that Ndr2 is critical
for the initiation of these processes but additional factors are
involved in the maintenance of LFA-1 open conformation and
FLNa phosphorylation.
In addition to Ndr2, the p21-activated kinase 1 (Pak1) has
been described to phosphorylate FLNa at S2152 in vitro and in
vivo (68). This kinase is recruited to the immunological synapse
(IS) (69, 70). In Jurkat T cells a trimolecular complex was
identified consisting of Pak, the guanine nucleotide exchange
factor PIX and the ADF-ribosylation factor-activating protein
(Arf-GAP) GIT (69). The recruitment of Pak to the IS is
dependent on the interaction with PIX and is also important
for its activation (69). Evidence that activated Pak might be
involved in TCR-mediated LFA-1 activation is shown by the
study of Missi (70). Here the authors analyzed α-PIX-deficient
T cells. Molecular events that were altered in these lymphocytes
include decreased GIT2 (an isoform of GIT) expression, Pak
phosphorylation and recruitment of Pak and LFA-1 to the IS
(70). The reduced LFA-1 in the IS correlates with an attenuated
interaction of α-PIX-deficient T cells with APCs (70). Pak1
might also indirectly regulate TCR-mediated LFA-1 activation
and adhesion through activation of phospholipase C gamma
1 (PLCγ1) to promote Rap1 activation. The disruption of
the PIX-Pak interaction or the overexpression of a dominant
negative mutant of Pak attenuated PLCγ1 phosphorylation
upon stimulation with superantigen-loaded B cells (69) or
after TCR triggering with antibodies (71). PLCγ1 hydrolyzes
phosphatidylinositol 4,5-biphosphate to produce diacylglycerol
(DAG) and Inositol triphosphate (IP3), which in turn increases
the level of intracellular free calcium (72). Katagiri and colleagues
identified a guanine nucleotide exchange factor that contains
both calcium and DAG binding domains (CalDAG-GEFI)
downstream of PLCγ1 that regulated TCR-mediated Rap1
activation to facilitate T-cell adhesion (73). However, whether
Pak1 regulates TCR-mediated adhesion independently of FLNa
phosphorylation at S2152 via Rap1 activation or is interrelated
with the Ndr2-pathway of FLNa phosphorylation clearly requires
further investigations.
In conclusion we demonstrate that the serine/threonine kinase
Ndr2, in addition to its critical role for apoptosis, cell polarity
and proliferation (34, 35), is indispensable for TCR-induced LFA-
1 activation. Ndr2-dependent phosphorylation of FLNa at S2152
seems to be the initial step of LFA-1 activation to switch from
the closed to the open high affinity conformation of this integrin
required for ligand binding.
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